Consumers who bought certain generic prescription drugs between May 1, 2009, and December 31, 2019, can now file claims for a share of $96 million in price-fixing settlements, a coalition of 48 attorneys general said on September 22. A federal court in Connecticut has preliminarily approved the plan to distribute the money, and claims are due by March 8, 2027. Eligibility turns on where a claimant lives now, not where the drugs were bought, and the covered list includes medicines widely used by older Americans for blood pressure, gout, depression and nerve pain.
Who can claim a share of the $96 million
New York Attorney General Letitia James said in a September 22 announcement that she joined 47 other attorneys general in urging eligible consumers to submit claims. The U.S. District Court for the District of Connecticut recently gave preliminary approval to the coalition’s plan to distribute tens of millions of dollars to people who overpaid for the drugs. “These companies inflated generic drug prices and forced hard-working families to pay excessive amounts for essential medications,” James said.
According to the official AG Generic Drugs settlement website, run by administrator Rust Consulting, an individual may be eligible if he or she bought one or more of the covered drugs in the United States during the 2009-to-2019 period, did not buy them for resale or directly from a defendant, and is not an officer or employee of a defendant. The claimant must currently live in a participating state, commonwealth or territory. The administrator says eligibility is based on the state of residence when the claim is filed, so a retiree who filled prescriptions in one state and later moved to another participating state is not shut out.
The 48 participating jurisdictions include New York, Connecticut, California, Florida, Pennsylvania, Ohio and most other states, plus the District of Columbia, Puerto Rico, the U.S. Virgin Islands and the Northern Mariana Islands. Residents of Guam and American Samoa are excluded.
A 2009-to-2019 purchase window and a 2027 filing deadline are easy to mix up. The four-date rule for reading a settlement notice in The Settlement & Refund Recovery System helps sort out which date controls eligibility and which one controls the claim.
Which drugs are covered
The settlements stem from three lawsuits alleging a coordinated scheme to fix prices, avoid competition and rig bids on more than 100 generic drugs. The first complaint, filed in 2016, named 18 companies and two individuals and concerned 15 drugs. The second, filed in 2019, named 22 of the largest generic manufacturers and 16 senior executives. The third, filed in 2020, focused on 80 topical generics such as creams and ointments and named 26 companies and 10 individuals.
The administrator’s drug list includes tablets, capsules, creams and ointments. Among the entries are allopurinol, used for gout; amitriptyline, used for depression and chronic nerve pain; atenolol combined with chlorthalidone, used for high blood pressure; albuterol tablets for lung conditions; and acetazolamide, used for glaucoma. The New York announcement also points to digoxin, a heart medication made by Heritage that tripled in price. In some cases, James said, coordinated increases topped 1,000%.
The list is organized by active ingredient, form and strength, and the administrator cautions that the court-filed notice controls. A drug with the right name but a different form or strength may not qualify, and the purchase must fall within the alleged conspiracy period for that particular drug. The administrator also notes the lawsuits do not question the safety or effectiveness of any of the medicines.
How the money was recovered and what is still pending
The $96 million comes from settlements with Apotex and Heritage, Bausch and Lannett, and Glenmark Pharmaceuticals USA. As part of those deals, the settling companies agreed to cooperate in the continuing cases and to adopt reforms aimed at preventing future misconduct. Seven pharmaceutical executives are also cooperating with the states, according to the attorney general.
Many large manufacturers have not settled. The administrator lists remaining defendants including Teva, Mylan, Sandoz, Sun, Taro, Lupin, Greenstone and others, and says more money could become available through a trial or future settlements, though there is no guarantee. People can register on the settlement website or by calling 1-866-290-0182 to be notified of any later settlement.
The settlement website also sets an October 15, 2026, postmark deadline for anyone who wants to be excluded from the Glenmark settlement. A consumer who opts out gives up a share of that settlement’s money; one who does nothing stays in and can still file a claim for payment.
How to file before March 8, 2027
Claims can be filed online through the official settlement website. The attorney general’s office says consumers can also request a paper form by emailing info@aggenericdrugs.com, calling 1-866-290-0182 or writing to the mailing address posted on the site.
Individual payment amounts are not yet known. The administrator says each award will depend on the number and size of valid claims, the money available and the distribution plan the court approves. The $96 million is the total recovered, not a per-person figure, and part of each settlement goes to administration and litigation costs.
Older claimants who no longer have pharmacy receipts from a decade ago still have options. Many pharmacy chains can print a prescription history, and Medicare Part D plans and insurers keep claims records. Gathering those records before filing makes it easier to match purchases to the covered list and dates. Any call or email that asks for a fee, a Social Security number or bank details up front in exchange for a “guaranteed” generic-drug payment should be treated as a scam, since the only official channels are the settlement website, its phone line and the participating attorneys general.
Old prescriptions, new deadline
A claim built on purchases from as far back as 2009 depends on paperwork many households have long since thrown away, and the March 2027 cutoff will arrive faster than a pharmacy records request sometimes does.
The Settlement & Refund Recovery System includes a step-by-step filing walkthrough, a claim log and payment tracker for following a claim after it is submitted, and the scam-proof rules for spotting fake settlement calls.
Keep this claim and every other open settlement on one page with The Settlement & Refund Recovery System.
This article was prepared with AI assistance and reviewed against the linked official sources.
